Lily Dara, MD

Title(s)Assistant Professor of Medicine
SchoolKeck School of Medicine of USC
Phone+1 323 442 5576
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    American Association for the Study of Liver Disease2007Resident Scholar Award
    American Association for the Study of Liver Disease2011Presidential Poster of Distinction
    Keck School of Medicine of USC2015USC RCLD Junior Faculty Transition Award
    NIH, NIDDK2016  - 2021K08 Mentored Clinical Scientist Development Award

    Collapse Overview 
    Collapse Overview
    Dr. Dara is an NIH funded physician-scientist and a general gastroenterologist. She provides consultation for general GI disorders including abdominal pain, acid reflux disease, GI blood loss and performs endoscopies and colonoscopies on the in patient service at Keck Hospital. Her research focuses mainly on disorders of the liver including drug induced liver injury and acute liver failure.

    Dr. Dara earned her medical degree from Shahid Beheshti University of Medical Sciences. She then served as chief resident at Griffin Hospital and then completed her fellowship in gastroenterology and hepatology at LAC+USC Medical Center.

    Collapse Research 
    Collapse Research Activities and Funding
    Role of RIPK1 and RIPK3 in liver injury.
    NIH/NIDDK K08DK109141Jul 1, 2016 - May 31, 2021
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Dara L. The Receptor Interacting Protein Kinases in the Liver. Semin Liver Dis. 2018 02; 38(1):73-86. PMID: 29471568.
      View in: PubMed
    2. Iorga A, Dara L, Kaplowitz N. Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis. Int J Mol Sci. 2017 May 09; 18(5). PMID: 28486401.
      View in: PubMed
    3. Dara L, Liu ZX, Kaplowitz N. Questions and controversies: the role of necroptosis in liver disease. Cell Death Discov. 2016; 2:16089. PMID: 27924226.
      View in: PubMed
    4. Dara L, Liu ZX, Kaplowitz N. A murder mystery in the liver: who done it and how? J Clin Invest. 2016 11 01; 126(11):4068-4071. PMID: 27760053.
      View in: PubMed
    5. Suda J, Dara L, Yang L, Aghajan M, Song Y, Kaplowitz N, Liu ZX. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-?B. J Immunol. 2016 10 15; 197(8):3120-3129. PMID: 27605011.
      View in: PubMed
    6. Dara L, Kaplowitz N. The many faces of RIPK3: What about NASH? Hepatology. 2016 11; 64(5):1411-1413. PMID: 27338154.
      View in: PubMed
    7. Sheibani S, Khemichian S, Kim JJ, Hou L, Yan AW, Buxbaum J, Dara L, Laine L. Randomized trial of 1-week versus 2-week intervals for endoscopic ligation in the treatment of patients with esophageal variceal bleeding. Hepatology. 2016 08; 64(2):549-55. PMID: 27082942; PMCID: PMC4956532 [Available on 08/01/17].
    8. Dara L, Kaplowitz N. Reply. Hepatology. 2016 07; 64(1):312-3. PMID: 26418131.
      View in: PubMed
    9. Dara L, Liu ZX, Kaplowitz N. Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications. Liver Int. 2016 Feb; 36(2):158-65. PMID: 26484420; PMCID: PMC4718752 [Available on 02/01/17].
    10. Dara L, Kaplowitz N. Reply. Hepatology. 2016 07; 64(1):308-9. PMID: 26390377.
      View in: PubMed
    11. Dara L, Johnson H, Suda J, Win S, Gaarde W, Han D, Kaplowitz N. Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis. Hepatology. 2015 Dec; 62(6):1847-57. PMID: 26077809.
      View in: PubMed
    12. Kaplowitz N, Win S, Than TA, Liu ZX, Dara L. Targeting signal transduction pathways which regulate necrosis in acetaminophen hepatotoxicity. J Hepatol. 2015 Jul; 63(1):5-7. PMID: 25770661.
      View in: PubMed
    13. Blumenfeld CM, Sadtler BF, Fernandez GE, Dara L, Nguyen C, Alonso-Valenteen F, Medina-Kauwe L, Moats RA, Lewis NS, Grubbs RH, Gray HB, Sorasaenee K. Cellular uptake and cytotoxicity of a near-IR fluorescent corrole-TiO2 nanoconjugate. J Inorg Biochem. 2014 Nov; 140:39-44. PMID: 25061689.
      View in: PubMed
    14. Peng H, Dara L, Li TW, Zheng Y, Yang H, Tomasi ML, Tomasi I, Giordano P, Mato JM, Lu SC. MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer. Hepatology. 2013 Jun; 57(6):2299-313. PMID: 23325601; PMCID: PMC3642222.
    15. Han D, Dara L, Win S, Than TA, Yuan L, Abbasi SQ, Liu ZX, Kaplowitz N. Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. Trends Pharmacol Sci. 2013 Apr; 34(4):243-53. PMID: 23453390; PMCID: PMC3622802.
    16. Han D, Ybanez MD, Johnson HS, McDonald JN, Mesropyan L, Sancheti H, Martin G, Martin A, Lim AM, Dara L, Cadenas E, Tsukamoto H, Kaplowitz N. Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice: biogenesis, remodeling, and functional alterations. J Biol Chem. 2012 Dec 07; 287(50):42165-79. PMID: 23086958; PMCID: PMC3516762.
    17. Dara L, Ji C, Kaplowitz N. The contribution of endoplasmic reticulum stress to liver diseases. Hepatology. 2011 May; 53(5):1752-63. PMID: 21384408; PMCID: PMC3082587.
    18. Dara L, Hewett J, Lim JK. Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol. 2008 Dec 07; 14(45):6999-7004. PMID: 19058338; PMCID: PMC2773866.